Keith Z. Hazleton

957 total citations · 1 hit paper
15 papers, 725 citations indexed

About

Keith Z. Hazleton is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Keith Z. Hazleton has authored 15 papers receiving a total of 725 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 10 papers in Molecular Biology and 8 papers in Epidemiology. Recurrent topics in Keith Z. Hazleton's work include Biochemical and Molecular Research (7 papers), HIV/AIDS drug development and treatment (7 papers) and Clostridium difficile and Clostridium perfringens research (4 papers). Keith Z. Hazleton is often cited by papers focused on Biochemical and Molecular Research (7 papers), HIV/AIDS drug development and treatment (7 papers) and Clostridium difficile and Clostridium perfringens research (4 papers). Keith Z. Hazleton collaborates with scholars based in United States, Netherlands and Panama. Keith Z. Hazleton's co-authors include Catherine Lozupone, Michael Kriss, Nichole Nusbacher, Casey Martin, Vern L. Schramm, María B. Cassera, Yong Zhang, Peter C. Tyler, Keith Clinch and Douglas R. Crump and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and PLoS ONE.

In The Last Decade

Keith Z. Hazleton

15 papers receiving 710 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Low diversity gut microbiota dysbiosis: drivers, functional implications and recovery

2018 294 citations Michael Kriss, Keith Z. Hazleton et al. Current Opinion in Microbiology profile →

Peers

Countries citing papers authored by Keith Z. Hazleton

Since Specialization

Citations

This map shows the geographic impact of Keith Z. Hazleton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Z. Hazleton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Z. Hazleton more than expected).

Fields of papers citing papers by Keith Z. Hazleton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith Z. Hazleton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Z. Hazleton. The network helps show where Keith Z. Hazleton may publish in the future.

Co-authorship network of co-authors of Keith Z. Hazleton

This figure shows the co-authorship network connecting the top 25 collaborators of Keith Z. Hazleton. A scholar is included among the top collaborators of Keith Z. Hazleton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith Z. Hazleton. Keith Z. Hazleton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	The Impact of Diet on Clostridioides difficile Infection: A Review 2025 ·The Journal of Infectious Diseases ·(unknown), Heidi J. Silver, Keith Z. Hazleton, Catherine Lozupone, Maribeth R. Nicholson	1
2	A Multimodal Intervention to Reduce C. difficile Infections and Stool Testing 2024 ·PEDIATRICS ·Jillian M. Cotter, (unknown), Suhong Tong, Meghan Birkholz, Jason Child, Carrye Cost, (unknown), Stéphanie Cox, Susan A. Dolan, Kathleen Dorris, Keith Z. Hazleton, (unknown), (unknown), Kelly Pearce, Samuel R. Dominguez	1
3	Gastric injury secondary to button battery ingestions: a retrospective multicenter review 2020 ·Gastrointestinal Endoscopy ·(unknown), Wenly Ruan, (unknown), Michael Wilsey, Douglas S. Fishman, (unknown), Zhaoxing Pan, Keith Z. Hazleton, Robert Krämer, T.G. Walker	16
4	2019 Gut Microbiota for Health World Summit 2019 ·Gastroenterology ·Gwenny M. Fuhler, Gail Hecht, Sage E. Foley, (unknown), Keith Z. Hazleton	4
5	Multiple-Ascending-Dose Phase 1 Clinical Study of the Safety, Tolerability, and Pharmacokinetics of CRS3123, a Narrow-Spectrum Agent with Minimal Disruption of Normal Gut Microbiota 2019 ·Antimicrobial Agents and Chemotherapy ·(unknown), (unknown), (unknown), George A. Saviolakis, Wael Elamin, Blaire L. Osborn, Jacques Ravel, Keith Z. Hazleton, Catherine Lozupone, Ronald J. Evans, Stacie Bell, Urs A. Ochsner, Thale C. Jarvis, Shahida Baqar, Nebojša Janjić	22
6	Low diversity gut microbiota dysbiosis: drivers, functional implications and recovery breakdown → 2018 ·Current Opinion in Microbiology ·Michael Kriss, Keith Z. Hazleton, Nichole Nusbacher, Casey Martin, Catherine Lozupone	294
7	Transition State Analogues of Plasmodium falciparum and Human Orotate Phosphoribosyltransferases 2013 ·Journal of Biological Chemistry ·Yong Zhang, Gary B. Evans, Keith Clinch, Douglas R. Crump, Lawrence D. Harris, (unknown), Peter C. Tyler, Keith Z. Hazleton, María B. Cassera, Vern L. Schramm	17
8	Acyclic phosph(on)ate inhibitors of Plasmodium falciparum hypoxanthine-guanine-xanthine phosphoribosyltransferase 2013 ·Bioorganic & Medicinal Chemistry ·Keith Clinch, Douglas R. Crump, Gary B. Evans, Keith Z. Hazleton, Jennifer M. Mason, Vern L. Schramm, Peter C. Tyler	32
9	Acyclic Immucillin Phosphonates: Second-Generation Inhibitors of Plasmodium falciparum Hypoxanthine- Guanine-Xanthine Phosphoribosyltransferase 2012 ·Chemistry & Biology ·Keith Z. Hazleton, Meng-Chiao Ho, María B. Cassera, Keith Clinch, Douglas R. Crump, (unknown), Emilio Merino, S.C. Almo, Peter C. Tyler, Vern L. Schramm	58
10	Plasmodium falciparum Parasites Are Killed by a Transition State Analogue of Purine Nucleoside Phosphorylase in a Primate Animal Model 2011 ·PLoS ONE ·María B. Cassera, Keith Z. Hazleton, Emilio Merino, Nicanor Obaldía, (unknown), Andrew S. Murkin, (unknown), Jemy A. Gutierrez, Steven C. Almo, Gary B. Evans, Y.S. Babu, Vern L. Schramm	55
11	Purine and Pyrimidine Pathways as Targets in Plasmodium falciparum 2011 ·Current Topics in Medicinal Chemistry ·María B. Cassera, Yong Zhang, Keith Z. Hazleton, Vern L. Schramm	117
12	Transport of purines and purine salvage pathway inhibitors by the Plasmodium falciparum equilibrative nucleoside transporter PfENT1 2009 ·Molecular and Biochemical Parasitology ·Paul M. Riegelhaupt, María B. Cassera, (unknown), Keith Z. Hazleton, (unknown), Vern L. Schramm, Myles H. Akabas	29
13	Erythrocytic Adenosine Monophosphate as an Alternative Purine Source in Plasmodium falciparum 2008 ·Journal of Biological Chemistry ·María B. Cassera, Keith Z. Hazleton, Paul M. Riegelhaupt, Emilio F. Merino, Minkui Luo, Myles H. Akabas, Vern L. Schramm	37
14	Structural characterization of the fusion of two pentapeptide repeat proteins, Np275 and Np276, from Nostoc punctiforme: Resurrection of an ancestral protein 2007 ·Protein Science ·M.W. Vetting, Subray S. Hegde, Keith Z. Hazleton, John S. Blanchard	31
15	Anopheles gambiaePurine Nucleoside Phosphorylase: Catalysis, Structure, and Inhibition^, 2007 ·Biochemistry ·Erika A. Taylor, Agnes Rinaldo-Matthis, Lei Li, Mahmoud Ghanem, Keith Z. Hazleton, María B. Cassera, Steven C. Almo, Vern L. Schramm	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact